Works matching IS 15330028 AND DT 2019 AND VI 18 AND IP 3


Results: 13
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

    Published in:
    2019
    By:
    • Borg, Christophe;
    • Mantion, Georges;
    • Boudghene, Frank;
    • Mornex, Fran<;oise;
    • Ghiringhelli, Francois;
    • Adenis, Antoine;
    • Azria, David;
    • Balosso, Jacques;
    • Abdelghani, Meher Ben;
    • Bachet, Jean Baptiste;
    • Vendrely, Veronique;
    • Francois, Yves;
    • Conroy, Thierry;
    • Rio, Emmanuel;
    • Roullet, Bernard;
    • Spaeth, Dominique;
    • Quero, Laurent;
    • Lakkis, Zaher;
    • Coudert, Mathieu;
    • Ionescu-Goga, Miruna
    Publication type:
    journal article
    10
    11

    Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP).

    Published in:
    2019
    By:
    • Riechelmann, Rachel P.;
    • Srimuninnimit, Vichien;
    • Bordonaro, Roberto;
    • Kavan, Petr;
    • Bartolomeo, Maria Di;
    • Maiello, Evaristo;
    • Cicin, Irfan;
    • Garcéa-Alfonso, Pilar;
    • Chau, Ian;
    • Fedyanin, Mikhail Y.;
    • Martos, Carlos Fernández;
    • Ter-Ovanesov, Mikhail;
    • Peeters, Marc;
    • Ko, Yoo-Joung;
    • Yalcin, Suayib;
    • Karthaus, Meinolf;
    • Aparicio, Jorge;
    • Heinemann, Volker;
    • Picard, Pascaline;
    • Bury, Denise
    Publication type:
    journal article
    12
    13